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As the most common progressive neurodegenerative disorder, Alzheimer’s disease (AD) has
been predominantly found in people 65 years of age or older. AD is associated with gradual
decline in cognitive impairment and memory as well as effects on behavior and decision making.
AD is also responsible for the most dementia cases in elderly people. As per the Alzheimer’s
Association facts, over 5 million Americans were affected by AD in 2018 whereas the number is
predicted to rise to approximately 14 million in 2050. One of the causes of AD is mis-cleavage of
the transmembrane protein called amyloid precursor protein (APP) by the enzymes β-secretase
and γ-secretase, resulting in accumulation of amyloid beta-42 polypeptide (Aβ42). These amyloid
beta peptides aggregate into hydrophobic plaques in the extracellular region in the brain altering
the cellular pathways and resulting in neuronal death. In this study, we have used Drosophila as
a model system and misexpressed the human Aβ42 in the photoreceptors of the Drosophila eye.
The misexpression of the Aβ42 in the Drosophila eye triggers the neuronal cell death resulting in
a glassy reduced eye phenotype. This study focusses on how microRNA mir-277 regulates the
Aβ42 mediated neurodegeneration. MicroRNA regulate the gene expression posttranscriptionally and repress the protein formation by sequence specific degradation of target
mRNA. Earlier studies have shown the association of microRNA in AD and the role of mir-277 in
AD is not clear. This study adds to our understanding of the role mir-277 may play in Aβ42
mediated neurodegeneration and its potential role as a biomarker for AD.
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Proof of concept for our Drosophila eye model
Misexpression of Aβ42 in fly
eye by GMR-GAL4 exhibits
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Hid is the target for Aβ42 mediated
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Misexpression of Amyloid (Aβ42)
results in formation of
extracellular plaques in the eye
Neuronal loss due to:
1. Amyloid Plaques
3. Oxidative stress due to ROS

miRNA-277 modulates the Aβ42 mediated neurodegeneration
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miRNA plays role in post transcriptional regulation

Conclusion

Future Directions

20
Ventral

Pupa

Egg
Pre-pupa

Life Cycle of
Fruit fly

IIIrd

Ist
Instar

• To check if Hid is the target of
miR277 which might enhance
Aβ42- mediated
neurodegeneration

• Blocking the activity of miR-277
suppresses Aβ42 - mediated
neurodegeneration
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• Hid is expressed in Aβ42
expressing flies
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• Overexpression of miR-277
enhances Aβ42- mediated
neurodegeneration with cuticular
growth
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Determine the targets of miR277

• Determine the mechanism of
action by which enhancement
and suppression phenotypes
are established

Acknowledgement: We would like to thank Bloomington Stock Center & DSHB for the reagents. AS is supported by NIH1R15GM124654-1, Schuellein Chair Endowment Fund, STEM Catalyst Grant from
University of Dayton and start-up support from UD.

